Thalys Medical Technology Group Inc.SSE: 603716

Announcement on Sale of Equity in Holding Subsidiary

· Issued by Thalys Medical Technology Group Inc. via Shanghai Stock Exchange

Filed with SSE · · 9 pages · Chinese

Summary by 6ix AI

The board approved the transaction, which does not require shareholder approval and is not classified as a related party transaction or a major asset restructuring. The sale aims to optimize the company's asset structure and enhance operational efficiency without adversely affecting its core business or financial results.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Thalys Medical Technology Group Inc. on 6ix

Earlier from Thalys Medical Technology

Later from Thalys Medical Technology

All Thalys Medical Technology news releases